Editor's Note Liver resection provides a significant survival benefit over percutaneous radiofrequency ablation (PRFA) or transarterial chemoembolization (TACE) in patients with early multinodular hepatocellular carcinoma (HCC), according to findings published May 15 in JAMA Surgery. Thus, liver resection should be considered the first therapeutic option in patients with early multinodular…